about
Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone.Necdin, a p53-target gene, is an inhibitor of p53-mediated growth arrest.An essential role for Ran GTPase in epithelial ovarian cancer cell survival.Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastasesSignature of a silent killer: expression profiling in epithelial ovarian cancer.CCN3 modulates bone turnover and is a novel regulator of skeletal metastasisExpression of Stem Cell Markers in Preinvasive Tubal Lesions of Ovarian Carcinoma.Gene expression profiling of primary cultures of ovarian epithelial cells identifies novel molecular classifiers of ovarian cancer.GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis.Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional study.Claudin-2 is selectively enriched in and promotes the formation of breast cancer liver metastases through engagement of integrin complexes.Biopsy Based Proteomic Assay Predicts Risk of Biochemical Recurrence after Radical Prostatectomy.Canadian Men's perspectives about active surveillance in prostate cancer: need for guidance and resources.Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion.A Multi-Institutional Validation of Gleason Score Derived from Tissue Microarray Cores.The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis.BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer.From gene profiling to diagnostic markers: IL-18 and FGF-2 complement CA125 as serum-based markers in epithelial ovarian cancer.Describing perspectives of health care professionals on active surveillance for the management of prostate cancer.The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validationIdentification of the Transcription Factor Relationships Associated with Androgen Deprivation Therapy Response and Metastatic Progression in Prostate CancerDNA Damage Signaling and Apoptosis in Preinvasive Tubal Lesions of Ovarian CarcinomaAn apoptotic molecular network identified by microarray: On the TRAIL to new insights in epithelial ovarian cancerSET complex in serous epithelial ovarian cancerDiscrimination between serous low malignant potential and invasive epithelial ovarian tumors using molecular profilingAfadin cooperates with Claudin-2 to promote breast cancer metastasisValidation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker NetworkCCN3/Nephroblastoma Overexpressed Is a Functional Mediator of Prostate Cancer Bone Metastasis That Is Associated with Poor Patient Prognosis
P50
Q33387074-517D1F97-3CA0-4745-A6C7-BC417A506DF6Q33739392-628A8E25-6B02-4AB0-9F05-78D89B86C1ECQ34166515-1963E641-B1E9-468D-B25B-CA6C5815B0A5Q34243626-DF22BB34-F48B-420C-819F-578E6C917EFBQ35549911-08AB1C8F-4C86-4D5F-B87F-891F1FD00B10Q35680306-5EE3456A-2CC0-43F3-8C24-B9B80956DE32Q36010515-B5A76E9A-6285-489E-AC1B-55ECEE312ECCQ36172983-9690B304-8F51-4C81-8C74-39E26360D790Q36613726-AC5482EA-E567-4EA0-A65D-928C3FBD81A9Q38899852-32CE349F-2839-4393-B0B7-F8779C681999Q38905626-7CC5130D-F961-4067-9A1C-555C3D8F62A5Q39631925-8064EBE4-47ED-42D3-9FF8-A09619C2B5CBQ40547488-EA15B239-8209-4DED-9DA8-4E0A28BFD037Q43248234-F1AEF8C1-E0AB-4C08-8C3B-55850BF9EC9DQ49574243-A297B1F4-82C3-424A-B827-135FFA96D3B8Q52603340-1E92817B-FB5B-473D-88B4-42314084E69FQ53529807-2A99AE2F-C6E0-41F5-A997-31220164D729Q54538068-08DC18ED-93D7-408E-A625-08756ABED807Q54636848-24B3EF65-6D4B-4276-9BB6-E6B7EB71A1B4Q55417451-9756379B-1CC4-4A3D-ADB9-FD43F81166F7Q57106119-6DC8AB4D-EB20-4A4D-AD50-D54082D9088DQ57475174-79E81473-E430-4905-BD17-D3635EBBF5CBQ58325136-7B99C711-643C-40C2-83A1-4032C486C840Q58325213-35B58A4A-F5CA-423C-B444-CE9802738A5DQ58325223-449CD56C-6045-41AB-A120-A40CC1ADFC66Q58325237-3B26AEAE-6BF7-4897-846E-00A7EA169F2EQ64231562-0E3C788B-997C-4CD4-A6B8-79A7036BCECDQ91552562-584C8AEB-6A46-43FF-943B-068203B2DBFBQ92769039-A763C5C1-30C0-4DFE-8A60-F91C74C5D74F
P50
description
researcher
@en
wetenschapper
@nl
name
Véronique Ouellet
@en
Véronique Ouellet
@nl
type
label
Véronique Ouellet
@en
Véronique Ouellet
@nl
prefLabel
Véronique Ouellet
@en
Véronique Ouellet
@nl
P106
P31
P496
0000-0003-1854-7082